Clinical Trials

480 enrolled

Advanced Malignant Solid Tumors

NCT06771739 2026-03-13

A Pilot Unrestricted Payment Program for Early-stage Cancer Patients: the PAYMENT Trial

Malignant Solid Neoplasm

NCT07469982 2026-03-13

A Phase I Study of SY-9453 in Patients With Advanced Solid Tumors

122 enrolled

Advanced or Metastatic Solid Tumors With Homozygous MTAP Deletion

NCT07459920 2026-03-10

CAPTURE

156 enrolled

Advanced Malignant Solid Tumor

NCT07450352 2026-03-04

SEED-CRYO: Sequential 125I Seed Implantation Followed by Cryoablation vs Single-Modality Local Therapy in Unresectable Solid Tumors

150 enrolled

Unresectable Solid Tumors

NCT07446725 2026-03-03

A Study to Evaluate Safety, PK and Efficacy of GH55 in Combination With GH21 in Patients With Solid Tumors

152 enrolled

Advanced Solid Tumor Cancer

NCT07443020 2026-03-02

RIOT 4B

Other solid neoplasmThoracic

Mesothelioma, Malignant, Pleural Effusion, Malignant

NCT07437625 2026-02-27

Lesion-Allocated Therapy for Multiple Metastases and Tumor-Zoned Treatment for Bulky Tumors: A Phase II Study of Iodine-125 Seed Implantation Combined With Cryoablation in High-Burden Metastatic Disease

90 enrolled

High-Burden Metastatic Solid Tumors

NCT07438093 2026-02-27

Safety, Tolerability, and Preliminary Efficacy of Peginterferon α-2b in Combination With an Anti-PD-1 Antibody in Patients With Advanced or Metastatic Malignant Solid Tumors

Advanced Solid Tumors

NCT07420010 2026-02-19

An Open-label, Single-arm Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetic Profile, and Preliminary Efficacy of KT032 Cell Injection in Patients With Mesothelin-positive Advanced Solid Tumors.

GastrointestinalGynecologicOther solid neoplasmThoracic

24 enrolled

Colonic Neoplasms, Mesothelioma, Ovarian Neoplasms

NCT06827054 2026-02-18

Psilocybin With Psychotherapy for Improving Chronic Pain in Cancer Patients Requiring Opioids

Hematopoietic and Lymphatic System Neoplasm

NCT07417501 2026-02-18

Lenvatinib Plus PD-1 Inhibitor for Advanced Solid Tumors With 11q13 Amplification

Solid Tumors

NCT07141407 2026-02-11

Telephone-Based Coaching Sessions (TAC) to Improve Advance Care Planning Participation in Advanced Cancer Patients and Their Support Person

80 enrolled

Advanced Malignant Solid Neoplasm

NCT07234058 2026-02-11

LAG-MAPS

Other solid neoplasmThoracic

126 enrolled

Mesothelioma, Malignant

NCT07396090 2026-02-09

Study of KRAS-Specific Vaccine in Patients With KRAS-Mutated Solid Tumors

13 enrolled

Advanced Solid Tumor

NCT07385950 2026-02-04

Evaluation of the Diagnostic Efficacy of a αvβ6/FAP-Targeting Heterodimeric Probe in Patients With Malignant Solid Tumors

100 enrolled

PET / CT

NCT06772090 2026-02-03

Probiotic Supplementation During Cytotoxic Chemotherapy for Solid Tumor Malignancies

40 enrolled

Solid Tumor, Adult

NCT07363369 2026-01-23

Exploratory Clinical Study of FAP mRNA Vaccine in Patients With Advanced Malignant Solid Tumors

Advanced Malignant Solid Tumors

NCT07356856 2026-01-21

Efficacy and Safety of Microtransplantation for Advanced and Relapsed Solid Tumors

Advanced and Relapsed Solid Tumors

NCT07325123 2026-01-08

Malic Acid Supplementation Combined With Immunotherapy in Patients With Solid Tumors

Solid Tumor Malignancies

NCT07327411 2026-01-08

Cetuximab β Combined With PRaG Regimen in the Treatment of EGFR-positive Advanced Refractory Solid Tumors

40 enrolled

Advanced Refractory Solid Tumors

NCT07318649 2026-01-06

Phase 2 Clinical Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of GH21 Capsules Combined With D-1553 Tablets in Subjects With Locally Advanced or Metastatic Solid Tumors With the KRASG12C Mutation

120 enrolled

Locally Advanced or Metastatic Solid Tumors

NCT07306338 2025-12-29

Patient Interest in an Integrative Oncology Program at USC Norris Cancer Center: A Single-Institution Needs Assessment

Hematopoietic and Lymphatic System Neoplasm

NCT07307053 2025-12-29

Rare Tumor Focused Platform Study of Innovative Therapies and Technologies (PLATFORM2)

Other neoplasmOther solid neoplasm

600 enrolled

Rare Malignant Neoplasm

NCT05522491 2025-12-11

Olaparib in the Treatment of BRCA1/2 Unmutated and BRCA1 Promoter Methylated Recurrent and Metastatic Triple-negative Breast Cancer

Solid Tumor

NCT07274657 2025-12-10

SMILE

EndocrineGastrointestinalNETOther solid neoplasm

150 enrolled

Pancreas Adenocarcinoma (MSI-H)

NCT07257497 2025-12-02

Safety and Efficacy of Combining a Vitamin B6-Limited Diet With Immunotherapy in Solid Tumor Patients: A Clinical Study Protocol

Solid Tumor Cancer

NCT07245901 2025-11-24

Safety and Tolerability of a mRNA Vaccine Encoding Tumor-Specific Circular RNA Antigens in Combination With Anti-PD-1 Monoclonal Antibody in Patients With Advanced Solid Tumors

Solid Tumor

NCT07178938 2025-11-14

THERANOVA

BreastOther solid neoplasm

Solid Tumors

NCT06027983 2025-09-23

Chimeric Receptor T Cells With Trastuzumab in HER2+ Advanced Breast Cancer and Other Solid Tumors

BreastOther solid neoplasm

36 enrolled

HER2+ Advanced Breast Cancer

NCT07182435 2025-09-19

Exploratory Clinical Study of Personalized mRNA Tumor Vaccine RH125 in Patients With Advanced Solid Tumors

36 enrolled

Solid Tumor Malignancies

NCT07170787 2025-09-12

A Study of IMM2510 + IMM01 Combination Therapy in Patients With Advanced Solid Tumors

104 enrolled

Advanced Solid Tumors

NCT07128576 2025-09-04

Romiplostim N01 for the Treatment of Thrombocytopenia Associated With Radiotherapy-Combined Treatment Regimens in Patients With Solid Tumors

Solid Tumors

NCT07155811 2025-09-04

T-ECHNICO

100 enrolled

Immunotherapy

NCT07131345 2025-08-20

Study of Iparomlimab and Tuvonralimab Plus Chemotherapy in Malignant Mesothelioma

Other solid neoplasmThoracic

55 enrolled

Mesothelioma, Malignant, Mesothelioma

NCT07127822 2025-08-17

Assessing Iparomlimab and Tuvonralimab in Recurrent or Metastatic MSI-H/dMMR Gastric Cancer

GastrointestinalOther solid neoplasm

106 enrolled

Gastric / Gastroesophageal Junction Adenocarcinoma

NCT07101549 2025-08-03

Treating Nectin-4-positive Advanced Solid Tumors With R-Star001 (Nectin-4-CART-IL18)

25 enrolled

Advanced Solid Tumors

NCT07046780 2025-07-02

A Multicenter, Prospective, Non-Interventional Real-World Study of Iparomlimab and Tuvonralimab Injection (QL1706) in the Treatment of Locally Advanced or Metastatic Solid Tumors

90 enrolled

Solid Tumor Cancer

NCT07013851 2025-06-10

NADIA

GynecologicOther solid neoplasm

25 enrolled

MMRd/MSI-H Stage II-III Endometrial Cancer

NCT06991478 2025-05-28

SK-NK Injection in Patients With Advanced Solid Tumors Accompanied by Malignant Ascites

Solid Tumor, Malignant Ascites

NCT06970132 2025-05-14

Study of SY-5933 Plus CT-707 in Advanced Solid Tumors With KRAS p.G12C Mutation

102 enrolled

Advanced Solid Tumor

NCT06951425 2025-05-13

An Exploratory Clinical Study of the Efficiency and Safety of TH027 in the Treatment of Relapsed/Refractory Solid Tumors

24 enrolled

Solid Tumors

NCT06926751 2025-04-15

Telpegfilgrastim vs Filgrastim for Secondary Prevention of Chemotherapy-Induced Neutropenia in Pediatric Solid Tumors

132 enrolled

Phase 4 Not yet recruiting

Solid Tumors

NCT06824792 2025-02-13

SINGULARITY

3,000 enrolled

Advanced Solid Tumors

NCT06713148 2025-02-06

Study on the Safety and Efficacy of Intratumoral Administration of IDOV-SAFETM in the Treatment of Advanced Solid Tumors

42 enrolled

Advanced Malignant Solid Tumor

NCT06761417 2025-01-08

A Prospective, Single-arm Clinical Study of Liposomal Mitoxantrone Combination Regimen in the Treatment of Relapsed and Refractory Solid Tumors in Children, Adolescents and Young Adults

49 enrolled

Solid Tumors

NCT06762327 2025-01-07

Ensartinib in the Treatment of ALK Positive or MET Exon 14 Skipping Anvanced Solid Tumors Excluded Lung Cancer

Solid Tumors

NCT06755086 2025-01-01

TF-antigen Targeting Molecular Probe for PET Imaging in Solid Tumors

Solid Tumors

NCT06719856 2024-12-27

MMP14(MT1-MMP) Targeting Bicyclic Peptide Probe for PET Imaging in Solid Tumors

Solid Tumor

NCT06720298 2024-12-27

CD147 Targeting Peptide Probe for PET Imaging in Solid Tumors